Search for: "Classen Immunotherapies, Inc. v. Biogen Idec"
Results 1 - 20
of 50
Sort by Relevance
|
Sort by Date
18 Dec 2019, 9:59 pm
For example, in Classen Immunotherapies, Inc. v. [read post]
25 Nov 2015, 9:59 pm
Biogen IDEC and Momenta Pharmaceuticals, Inc. v. [read post]
25 Jun 2013, 9:52 pm
In Classen Immunotherapies, Inc. v. [read post]
12 Aug 2012, 11:47 am
Ct. 1289 (2012), according to the District Court in Classen Immunotherapies, Inc. v. [read post]
7 Aug 2012, 11:45 pm
Biogen IDEC, 659 F.3d 1057 (Fed. [read post]
7 Aug 2012, 7:43 pm
Biogen IDEC, 659 F.3d 1057 (Fed. [read post]
18 May 2012, 5:45 am
” See Ultramercial, p. 6; Classen Immunotherapies, Inc. v. [read post]
30 Mar 2012, 8:30 am
Biogen IDEC. [read post]
22 Mar 2012, 4:55 am
Cir. 2011); Classen Immunotherapies, Inc. v. [read post]
Review of the Effects of the Leahy-Smith America Invents Act on Third Party Participation Applicants
1 Feb 2012, 9:15 am
James G. [read post]
12 Dec 2011, 9:02 am
For example, in Classen Immunotherapies, Inc. v. [read post]
3 Nov 2011, 12:48 pm
Biogen IDEC, and CyberSource Corp. v. [read post]
20 Sep 2011, 9:59 pm
Mayo Collaborative Services) and may consider two others (Classen Immunotherapies, Inc. v. [read post]
19 Sep 2011, 3:17 am
(IPBiz) Deep thoughts by Chief Judge Rader: Classen Immunotherapies, Inc. v. [read post]
16 Sep 2011, 1:34 pm
§ 101; see Classen Immunotherapies, Inc. v. [read post]
10 Sep 2011, 12:32 am
(Spicy IP) (Spicy IP) US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al / ????????????????????????? [read post]
8 Sep 2011, 9:59 pm
Noonan -- Accompanying the Federal Circuit's majority decision in Classen Immunotherapies, Inc. v. [read post]
7 Sep 2011, 9:29 am
In Classen Immunotherapies, Inc. v. [read post]
7 Sep 2011, 8:03 am
.” ~Jack Handey Chief Judge Rader, joined by Circuit Judge Newman, offered their own deep thoughts in a concurring opinion on Classen Immunotherapies, Inc. v. [read post]
7 Sep 2011, 4:22 am
Highlights this week included: US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al (Inventive Step) (Orange Book Blog) (Patently-O) (Patent Docs) (Patent Docs) (IPBiz) (Patent Law Practice Center) (Patent Baristas) US: FTC issues long-awaited final report on authorized generics; report examines both the short-term effects and long-term impact on competition and drug prices (FDA Law Blog)… [read post]
